ZA982818B - Prevention of breast cancer using selective estrogen receptor modulators. - Google Patents
Prevention of breast cancer using selective estrogen receptor modulators.Info
- Publication number
- ZA982818B ZA982818B ZA9802818A ZA982818A ZA982818B ZA 982818 B ZA982818 B ZA 982818B ZA 9802818 A ZA9802818 A ZA 9802818A ZA 982818 A ZA982818 A ZA 982818A ZA 982818 B ZA982818 B ZA 982818B
- Authority
- ZA
- South Africa
- Prior art keywords
- prevention
- breast cancer
- estrogen receptor
- receptor modulators
- selective estrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/64—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4311897P | 1997-04-09 | 1997-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA982818B true ZA982818B (en) | 1999-10-04 |
Family
ID=21925594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9802818A ZA982818B (en) | 1997-04-09 | 1998-04-02 | Prevention of breast cancer using selective estrogen receptor modulators. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0975628A4 (en) |
| JP (1) | JP2001518897A (en) |
| KR (1) | KR20010006215A (en) |
| CN (1) | CN1259945A (en) |
| AU (1) | AU6957398A (en) |
| CA (1) | CA2286207A1 (en) |
| EA (1) | EA199900910A1 (en) |
| HU (1) | HUP0001845A2 (en) |
| ID (1) | ID23653A (en) |
| IL (1) | IL132279A0 (en) |
| NO (1) | NO994902L (en) |
| PL (1) | PL336206A1 (en) |
| TR (1) | TR199903244T2 (en) |
| WO (1) | WO1998045286A1 (en) |
| ZA (1) | ZA982818B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6610706B1 (en) | 1999-07-29 | 2003-08-26 | Eli Lilly And Company | Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| US6653479B1 (en) | 1999-07-29 | 2003-11-25 | Eli Lilly And Company | Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophene hydrochloride |
| JP5558358B2 (en) | 2007-10-16 | 2014-07-23 | レプロス セラピューティクス インコーポレイティド | TRANS-clomiphene for metabolic syndrome |
| CA2865234A1 (en) | 2012-02-29 | 2013-09-06 | Repros Therapeutics Inc. | Combination therapy for treating androgen deficiency |
| EP3360870A1 (en) | 2013-02-19 | 2018-08-15 | Novartis AG | Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders |
| GB201311888D0 (en) * | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| AU2016352592B2 (en) | 2015-11-10 | 2023-04-27 | Paracrine Therapeutics Ab | Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and an anti estrogen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5510357A (en) * | 1995-02-28 | 1996-04-23 | Eli Lilly And Company | Benzothiophene compounds as anti-estrogenic agents |
| PE44597A1 (en) * | 1995-02-28 | 1997-10-13 | Lilly Co Eli | BENZOTIOFEN COMPOUNDS, INTERMEDIATE PRODUCTS, COMPOSITIONS AND PROCEDURES |
| US5731342A (en) * | 1996-02-22 | 1998-03-24 | Eli Lilly And Company | Benzothiophenes, formulations containing same, and methods |
-
1998
- 1998-04-02 ZA ZA9802818A patent/ZA982818B/en unknown
- 1998-04-07 JP JP54309098A patent/JP2001518897A/en active Pending
- 1998-04-07 CA CA002286207A patent/CA2286207A1/en not_active Abandoned
- 1998-04-07 EP EP98915368A patent/EP0975628A4/en not_active Withdrawn
- 1998-04-07 EA EA199900910A patent/EA199900910A1/en unknown
- 1998-04-07 ID IDW991189A patent/ID23653A/en unknown
- 1998-04-07 PL PL98336206A patent/PL336206A1/en unknown
- 1998-04-07 WO PCT/US1998/006989 patent/WO1998045286A1/en not_active Application Discontinuation
- 1998-04-07 TR TR1999/03244T patent/TR199903244T2/en unknown
- 1998-04-07 HU HU0001845A patent/HUP0001845A2/en unknown
- 1998-04-07 AU AU69573/98A patent/AU6957398A/en not_active Abandoned
- 1998-04-07 KR KR1019997009295A patent/KR20010006215A/en not_active Application Discontinuation
- 1998-04-07 CN CN98805957A patent/CN1259945A/en active Pending
- 1998-04-07 IL IL13227998A patent/IL132279A0/en unknown
-
1999
- 1999-10-08 NO NO994902A patent/NO994902L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TR199903244T2 (en) | 2000-05-22 |
| NO994902L (en) | 1999-12-07 |
| ID23653A (en) | 2000-05-11 |
| IL132279A0 (en) | 2001-03-19 |
| KR20010006215A (en) | 2001-01-26 |
| EP0975628A4 (en) | 2001-03-21 |
| JP2001518897A (en) | 2001-10-16 |
| EP0975628A1 (en) | 2000-02-02 |
| AU6957398A (en) | 1998-10-30 |
| CN1259945A (en) | 2000-07-12 |
| EA199900910A1 (en) | 2000-04-24 |
| WO1998045286A1 (en) | 1998-10-15 |
| CA2286207A1 (en) | 1998-10-15 |
| PL336206A1 (en) | 2000-06-05 |
| HUP0001845A2 (en) | 2001-06-28 |
| NO994902D0 (en) | 1999-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200108846B (en) | Glucocorticoid receptor modulators. | |
| HK1035671A1 (en) | Adenosine a3 receptor modulators. | |
| EP0971588A4 (en) | Novel cannabinoid receptor modulators | |
| AU4557099A (en) | Novel therapeutic agents that modulate estrogen receptors | |
| ZA991301B (en) | Glutamate receptor modulators. | |
| AU1199600A (en) | Estrogen receptor ligands | |
| ZA966721B (en) | Bowl for hand mixing. | |
| HUP9700636A3 (en) | Novel estrogen receptor | |
| MXPA01011294A (en) | Tetracyclic progesterone receptor modulator compounds and methods. | |
| ZA982818B (en) | Prevention of breast cancer using selective estrogen receptor modulators. | |
| EP1084142A4 (en) | Gpr35a receptor | |
| EP0973800A4 (en) | Novel receptor | |
| ZA981338B (en) | Neurturin receptor. | |
| GB9928566D0 (en) | Human vanilloid receptor-like receptor | |
| GB9803062D0 (en) | Estrogen receptor ligands | |
| GB9913649D0 (en) | Estrogen receptor | |
| EP1083909A4 (en) | hCEPR RECEPTOR | |
| GB9722884D0 (en) | Estrogen receptor | |
| GB9711992D0 (en) | Estrogen receptor ligands | |
| GB9717346D0 (en) | Estrogen receptor ligands | |
| GB9806032D0 (en) | Estrogen receptor | |
| EP1109565A4 (en) | Gabab1aa receptor | |
| GB9803061D0 (en) | Estrogen receptor ligands | |
| GB9803202D0 (en) | Estrogen Receptor Ligands | |
| GB9808613D0 (en) | Receptor system |